Fabio Zanini is an Associate Professor at the University of New South Wales (UNSW) , leading a research group focused on computational biology , single-cell approaches , and transcriptomic analysis across diseases like severe dengue , neonatal lung disease , cancer , and marine biology . He previously conducted postdoctoral research at Stanford University (2016-2019) and earned a PhD in Bioinformatics from the Max Planck Institute for Developmental Biology and the University of Tuebingen (2015). Current Affiliation: Group leader, UNSW Previous Training: Postdoc (Stanford), PhD (Max Planck/University of Tuebingen) His research spans single-cell RNA sequencing , computational virology , developmental cell biology , and bioinformatics tool development , with recent work on: Severe dengue progression (viral-host interactions, immune signatures) Lung development (endothelial cell diversity, hyperoxia-induced injury) Cancer genomics (mutant HSC clones, AZA therapy response) Marine biology (plankton transcriptomics, evolutionary analysis) Bioinformatics (HTSeq 2.0, northstar algorithm) Recent scientific awards include grants from the Chan Zuckerberg Initiative ($270,000), NIH R01 (multiple), ARC Discovery Grant , and NHMRC Ideas Grant . Notable contributions include: Northstar - Cell classification algorithm SpectralSeq - Hyperspectral-transcriptomic integration Tabula Muris - Mouse aging atlas He has supervised research into hematopoietic stem cell regulation , lung vascular development , and autophagy in viral infections , with collaborations across Stanford , University of Sydney , and Harvard .
Dr. Shelley Wickham is an Associate Professor and ARC DECRA Fellow at the University of Sydney, holding joint appointments in the Schools of Chemistry and Physics. She serves as a Westpac Research Fellow and leads the DNA Nanotechnology Group at the Sydney Nano Institute. Dr. Wickham is also co-Champion of the Sydney Nano Institute Grand Challenge project in Molecular Nanorobotics for Health, co-lead of the School of Physics Grand Challenge on Nanoscale brain navigation for targeted drug delivery, and faculty mentor of the University of Sydney BIOMOD team. Bachelor of Science and Master of Science in Physics from University of Sydney PhD in Condensed Matter Physics from University of Oxford Postdoctoral Fellow at Harvard Medical School, Dana-Farber Cancer Institute, and Wyss Institute Dr. Wickham's research focuses on self-assembling nanotechnology and molecular robotics, particularly in the design and assembly of programmable nanostructures out of DNA. Her work spans applications in cell biology, materials science, and nanomedicine. Current research projects include design and synthesis of self-assembling DNA nanostructures, proto-cells made of DNA gels that move under flow, new plasma fabrication methods for biomolecule micropatterning, and DNA computation circuits for navigating the brain using machine learning. Her research aligns with the Faculty of Science Research Strengths in Molecules to Materials, Preventing and Treating Disease & Disorder, and Next Generation Materials. Analysis of Dr. Wickham's recent publications reveals a consistent focus on DNA nanotechnology with increasing sophistication in structural complexity and biological applications. Her work has evolved from fundamental DNA origami structures to increasingly complex multi-component systems with practical applications in nanomedicine and biomimetic engineering. Recent publications show strong interdisciplinary collaboration across chemistry, physics, biology, and engineering disciplines, with emphasis on real-world applications including drug delivery systems and biomolecular sensors. ARC DECRA Fellow Westpac Research Fellow BIOMOD World Champions (2019) Dr. Wickham actively mentors PhD students and postdoctoral researchers in her DNA nanotechnology group. She has secured significant research funding including ARC Discovery Projects, Westpac Scholarships, and NSW Health grants. Her current grants support projects such as '3D Bio-Nanomaterial Displays with Designer Architectures and Functions' and 'RNA aptamer sensing devices for rapid detection of blood clotting.' Dr. Wickham encourages applications from diverse backgrounds and maintains active collaborations with researchers at Harvard, Oxford, and other international institutions. Dr. Wickham leads the DNA Nanotechnology Group at the University of Sydney, which is part of the Sydney Nano Institute. Her lab focuses on building tools from DNA origami - including tweezers, spanners, wrenches and springs - to better understand biological processes at the nanoscale. The group has achieved notable success with the BIOMOD team winning world championships in 2019, and continues to develop innovative approaches to molecular robotics for healthcare applications.
Senani N.H. Rathnayake is a Research Fellow at the University of Technology Sydney (UTS), Faculty of Science. He completed his PhD at UTS (2019-2024) and held a Postdoctoral Fellowship at the University of Groningen (2023-2024). His primary research focuses on respiratory diseases, particularly the molecular mechanisms of smoking-induced lung damage, COPD, and asthma. Key areas include gene expression profiling, epigenetic changes, and cellular responses to cigarette smoke exposure. Research Interests: Transcriptomic and epigenetic alterations in lung diseases Smoking cessation effects on airway biology Genetic regulation of COPD biomarkers (e.g., sRAGE) Sex chromosome influences on respiratory disease susceptibility Awards & Fellowships: 2023 TSANZ Past Presidents Scholarship Award 2022-2023 European Respiratory Society Short-Term Fellowship Recent Research Trends: His articles emphasize smoking's impact on bronchial epithelial cells, including transcriptomic shifts, mucus barrier dynamics, and CRISPR-based gene-editing applications. Recent work explores Y-chromosome effects on COPD and asthma pathogenesis. Professional Engagement: Co-chair of the 2023 TSANZ Annual Scientific Conference Member of Australian Society for Medical Research, European Respiratory Society, and Thoracic Society of Australia and New Zealand
Dr Marten Moore is a Research Fellow at the Division of Plant Sciences, The Australian National University. His research focuses on understanding mRNA dynamics, plant stress responses, and photosynthesis efficiency through molecular and genetic approaches. He investigates how plants adapt to environmental stresses such as light fluctuations and salinity, with a particular emphasis on retrograde signaling pathways linking chloroplasts to nuclear responses. Dr Moore’s work integrates experimental and computational methods, including the development of tools like ConCysFind for analyzing conserved protein sequences across plant species. He collaborates on projects aimed at enhancing crop resilience through improved energy use efficiency and yield stability, leveraging insights from wheat and Arabidopsis models. Key Projects: Using RNA regulation to improve energy use efficiency and boost yield in wheat (2024–2027) Regulators of protein translation reveal new pathways to plant productivity (2022–2025) Smart Plants and Solutions for Enhancing Crop Resilience and Yield (2021–2025) His research interests span mRNA fate during stress recovery, nitric oxide signaling in plant cells, and the role of glutathione peroxidases in symbiotic root nodules. Dr Moore’s contributions bridge fundamental plant biology with applied agricultural challenges, aiming to translate molecular insights into practical solutions for sustainable agriculture.
Dr. Bei Bei is an Associate Professor at the School of Psychological Sciences, Monash University, and an NHMRC Emerging Leadership (EL2) Fellow. She leads the Behavioural Sleep Medicine service, research, and training at Monash University Healthy Sleep Clinic, focusing on individual differences in sleep-wake behaviors, sleep-mental health relationships, and community dissemination of evidence-based sleep interventions. Doctor of Psychology (Clinical), University of Melbourne PhD, University of Melbourne Her research spans six major areas: Sleep-wake circadian rhythm disorders Cognitive Behavioral Therapy for Insomnia (CBT-I) Psychological/behavioral aspects of sleep Sleep-mental health interactions (mood, anxiety) Adolescent sleep patterns and wellbeing Perinatal/postpartum sleep interventions for women Recent publications (2024-2025) address: Insomnia treatment mechanisms in depression comorbidity Neurodevelopmental impacts of circadian factors Pregnancy-related insomnia risk identification Adolescent sleep facilitators/barriers Integrated models for youth depression and sleep across continents She also contributes to: Antifungal drug tolerance mechanisms RNA polyadenylation dynamics Mitochondrial RNA stability in cancer 3' UTR splice variants in rare diseases Awarded the NHMRC Emerging Leadership (EL2) Fellowship and Early Career Research Grant , Dr. Bei serves on editorial boards for Sleep Medicine Reviews, Sleep, and Behavioral Sleep Medicine journals.
Maja Adamska is an Associate Professor and ARC Future Fellow at the Australian National University (ANU) in the Research School of Biology. She serves as Associate Director of Education and Head of the Biology Teaching and Learning Centre. Her primary research affiliation is with the Division of Biomedical Science and Biochemistry, where she leads the Adamska Group focused on the genomic and evolutionary basis of animal development. She is based in Room 2.022, Level 2, Linnaeus Building at ANU. Dr. Adamska studied biology with a focus on embryology and evolutionary biology at Jagiellonian University in Krakow, Poland. She completed her PhD in Germany working with Eva Bober and Thomas Braun on homeobox genes in inner ear development using vertebrate models from medaka fish to mice. Her postdoctoral work included research at the University of Michigan in Miriam Meisler's laboratory studying mouse mutants for limb patterning, followed by work at the University of Queensland with Bernie Degnan analyzing developmental signaling pathways in the sponge Amphimedon queenslandica. She was a group leader at the Sars International Centre for Marine Molecular Biology in Bergen, Norway from 2007-2015 before joining ANU in 2015. Her research addresses fundamental biological questions about how complex animals develop from single cells and how the first multicellular animals evolved from single-cell ancestors. She uses calcareous sponges to investigate the evolutionary origins of key developmental processes including germ layer segregation and axial patterning. Her work spans multiple areas including evolutionary developmental biology, comparative genomics, and the study of major transitions in animal evolution such as the emergence of multicellularity and morphological complexity. Her research has revealed surprising similarities between sponge and higher animal embryonic development, challenging traditional views of animal evolution. Analysis of Dr. Adamska's recent publications shows a strong focus on sponge and coral biology, with increasing attention to conservation and sustainability issues related to marine ecosystems. Her work combines molecular, genomic, and evolutionary approaches to understand fundamental biological processes, with particular emphasis on gene regulatory networks, developmental signaling pathways, and the genomic basis of morphological complexity in early-branching animals. ARC Future Fellow (since 2017) h-index of 32 with 3,990 citations according to Scopus Multiple research grants including ARC Centre of Excellence for Integrated Coral Reef Studies (2014-2021) Dr. Adamska supervises research on multiple projects including coral regeneration, molecular mechanisms of developmental signaling pathways in sponges, identification of target genes for developmental transcription factors, skeleton formation in corals and sponges, and sponge and coral microbiomes. She also serves as Convenor for BIOL2174 and has developed innovative educational approaches including the Digital Marine platform for blended learning in marine biology. Her research group, the Adamska Group, focuses on the genomic and evolutionary basis of animal development, using calcareous sponges as model organisms to gain insights into the evolutionary origins of complex developmental processes. The group collaborates with international researchers across multiple institutions to advance understanding of early animal evolution and development.
Lionel Hebbard is a Professor in the Department of Molecular and Cellular Biology at James Cook University's College of Medicine and Dentistry. His research spans hepatocellular carcinoma mechanisms, metabolic liver disease, and cancer therapeutics with significant contributions to adiponectin biology and sarcopenia assessment in cardiac surgery. James Cook University (Current) Department of Molecular and Cellular Biology College of Medicine and Dentistry Senior Researcher in Liver Cancer Biology His research focuses on hepatocellular carcinoma pathogenesis , particularly adiponectin signaling pathways and liver cancer stem cells. He investigates non-alcoholic fatty liver disease progression to cancer, metabolic drivers of tumorigenesis, and therapeutic targeting using aptamer-based delivery systems. Recent work explores sarcopenia quantification via CT imaging for cardiac surgery risk prediction, demonstrating clinical translation of his molecular findings. His lab employs advanced techniques including CRISPR screening (TARGET-SL platform), in vitro cancer models, and murine tumor systems. Analysis of his 15 most recent publications reveals strong emphasis on translational liver cancer research (60%), cardiac surgery complications (20%), and emerging biotechnologies (20%). Key trends include adiponectin's dual roles in fibrosis and tumorigenesis, sarcopenia as a surgical biomarker, and aptamer-based targeting of cancer stem cells. His work consistently bridges molecular mechanisms with clinical applications, particularly in hepatocellular carcinoma diagnostics and treatment. He mentors multiple doctoral students and early-career researchers including Rhys Gillman and Miriam Wankell. His research is supported by continuous funding from Australian NHMRC and international collaborations with George Jacob (Westmead Institute), Qiao Liang (Bentham Books), and Ranscht Barbara (T-cadherin studies). He leads the Hepatic Cancer Biology laboratory focusing on: Liver cancer stem cell characterization Adiponectin receptor signaling in HCC Metabolic drivers of tumor progression Novel drug delivery systems for liver cancer Translational sarcopenia assessment tools
Associate Professor Maja Adamska is a Group Leader and Associate Professor in the Research School of Biology at the Australian National University (ANU). She leads Program 3 in the ARC Centre of Excellence for Coral Reef Studies and has held previous roles as a Group Leader at the Sars International Centre for Marine Molecular Biology in Norway. Her research focuses on the evolutionary origins of developmental processes in animals, particularly using calcareous sponges as model systems. Adamska's work bridges developmental biology, genomics, and evolutionary biology, investigating topics such as germ layer segregation, axial patterning, and major transitions in animal evolution like the emergence of multicellularity. Education & Career: Bachelor's/Master's in Biology at Jagiellonian University (Kraków, Poland) PhD in Developmental Biology at the University of Cologne (Germany) Postdoctoral research at the University of Michigan and University of Queensland ARC Future Fellow at ANU since 2017 Research Interests: Genomic basis of morphological complexity Evolutionary origins of developmental processes Sponge and coral genomics Regeneration mechanisms in marine organisms Key Contributions: Discovered conserved developmental pathways in sponges Advanced understanding of sponge-metazoan divergence Contributed to the Amphimedon queenslandica genome project Awards: ARC Future Fellowship (2017–present) Lab & Collaborations: Adamska Group (Genomic and Evolutionary Basis of Animal Development) Collaborations with global marine biology networks
Dr. Andrew J. Woo is a Research Fellow at The University of Western Australia Medical School and the UWA Centre for Medical Research, affiliated with the Harry Perkins Institute of Medical Research. His research focuses on transcriptional gene regulation in stem/progenitor cells of blood and epithelial cancer stem cells. Dr. Woo completed his Bachelor of Science with Honours and PhD in Biochemistry at The University of Western Australia in 2004. He then pursued postdoctoral training under Dr. Alan B. Cantor at Children's Hospital Boston/Dana-Farber Cancer Institute at Harvard Medical School. He returned to Perth in 2012 with a fellowship from the Royal Perth Hospital Medical Research Foundation. Dr. Woo's research interests include understanding transcriptional gene regulatory mechanisms in stem/progenitor cells of blood and epithelial cancer stem cells. With Dr. Peter Leedman at the Harry Perkins Institute of Medical Research, he investigates the role of small non-coding RNA processing complexes in epithelial cancer onset and metastasis. His laboratory employs various techniques including protein-protein interaction identification via proteomics, protein-DNA interaction mapping, transcriptomics, functional genomics, and transgenic mouse models. His recent publications demonstrate a strong focus on cancer research, particularly breast cancer and hepatocellular carcinoma, with significant contributions to understanding transcription factors, oncogenes, and signaling pathways. His work often involves collaboration with other researchers at the Harry Perkins Institute and beyond. Dr. Woo has received the NHMRC project grant near-miss merit award in 2016 and has secured multiple research grants from organizations including Cancer Council of Western Australia and the Medical Research Foundation WA. Dr. Woo has been actively involved in research funding, serving as Chief Investigator on multiple grants since 2012. He also holds an external position as Lecturer and Unit Coordinator at Edith Cowan University from July 2018 to July 2043. His research is conducted within the UWA Centre for Medical Research, which is affiliated with the Harry Perkins Institute of Medical Research, a leading medical research facility in Western Australia.
Associate Professor Robert Nordon is a faculty member at UNSW Sydney's Graduate School of Biomedical Engineering. He holds an MB BS, BMedSci, and PhD, with research focusing on advanced manufacturing and medical technologies. Since 2016, he has secured over $5M in research grants for projects in point-of-care diagnostics, cell/gene therapy manufacturing, and stem cell science. Research interests span three primary domains: Developing microfluidic single-use disposables for scalable clinical cell production Modeling cardiovascular development using stem cell-based microfluidic systems Creating computational tools for single-cell analysis and lineage tracking His publications (2017-2024) demonstrate strong emphasis on microfluidic device engineering, stem cell dynamics, and biomaterials development. Recurring themes include hematopoietic stem cell expansion, cardiac cell behavior, and peptide-based biomaterials. Significant grants include: ARC Linkage Grant LP160100570: Scaling microfluidics for cell manufacture (2016-2019) ARC Linkage Grant LP160100573: 3D microstructures for medical devices (2016-2019) ARC Linkage Grant LP190100029: Electrophoretic cell sorters (2020-2023) CRC-P: Microbioreactor for affordable cell/gene therapy (2021-2023) Current research trainees include Farzaneh Ziaee and Eric Du.
Professor Marcel Dinger is a prominent academic and researcher currently serving as Professor and Head of School for Biotechnology and Biomolecular Sciences at UNSW Sydney. With over 20 years of experience in genomics, he has established himself as a leading figure in both academic and entrepreneurial spheres within the field. He has published 153 papers with over 24,000 citations and maintains an h-index of 61 on Google Scholar. His leadership extends beyond academia as he serves as President of the Australasian Genomics Technologies Association (AGTA) and holds director positions at Pryzm Health and the National Centre for Indigenous Genomics (NCIG). Professor Dinger's research laboratory focuses on establishing new links between phenotype and genotype, particularly examining rare and complex diseases in relation to underexplored regions of the genome including pseudogenes, repetitive elements, non-canonical DNA structures, and noncoding RNAs. His work harnesses population-scale genomic datasets and sophisticated data science methods to bring an objective perspective to understanding how the genome stores information and how it is transacted in biology. His research interests span genomics, non-coding RNA biology, clinical applications of genomic medicine, and the development of computational approaches for analyzing complex genomic data. Analysis of Professor Dinger's recent publications reveals a strong emphasis on non-coding RNA research, particularly long noncoding RNAs and their roles in disease mechanisms. His work spans cancer genomics, neurological disorders, and fundamental genomic mechanisms including DNA secondary structures like i-motifs and G-quadruplexes. His research combines experimental approaches with advanced bioinformatics to address fundamental questions in genomic medicine and has significant translational implications for disease diagnosis and treatment. Highly Cited Researcher in Cross-Field category (2019, 2020, 2021) Fellow of the Faculty of Science (Research), Royal Society of Pathologists of Australasia (2016) NHMRC Career Development Award (2010) Queensland Government Smart Futures Fellowship (2009) Foundation of Research, Science and Technology New Zealand Postdoctoral Fellowship (2005) Professor Dinger has been instrumental in establishing and leading several significant research initiatives including Genome.One, one of the first companies globally to provide clinical whole genome sequencing services, and the Kinghorn Centre for Clinical Genomics at the Garvan Institute of Medical Research. His entrepreneurial experience includes founding four biotechnology and IT startups. He serves on multiple governance boards including the National Centre for Indigenous Genomics, focusing on using genomics to improve health outcomes for Australia's First Peoples. His laboratory at UNSW continues to advance our understanding of genomic regulation and its implications for human health and disease.
Professor James Cook is a Theme Leader for Plants, Animals and Interactions at the Hawkesbury Institute for the Environment (HIE) at Western Sydney University. He holds the academic rank of Professor and leads research focused on ecology, evolution, and symbiosis, with particular emphasis on pollination systems and insect ecology. Professor Cook received his BA in Zoology from Oxford University and his PhD in Evolutionary Biology from Imperial College London. His previous academic appointments include positions at La Trobe University, Imperial College London, and the University of Reading. Professor Cook's research interests lie at the intersection of ecology, evolution, and symbiosis , with particular emphasis on pollination systems and insect-microbe interactions . His work spans multiple scales from molecular to ecosystem levels, investigating how species interactions shape biological communities. He is particularly renowned for his expertise in fig-pollinator mutualisms and stingless bee biology . His research integrates field studies, laboratory experiments, and molecular approaches to address fundamental questions in evolutionary ecology while also addressing applied challenges in agricultural pollination and conservation biology . Analysis of Professor Cook's recent publications reveals a strong focus on pollination ecology and insect-microbe symbioses . His work spans both fundamental research on evolutionary processes and applied studies addressing agricultural challenges. A significant portion of his recent work examines stingless bees as potential managed pollinators for Australian horticulture, alongside investigations into alternative pollinators beyond honey bees. His research increasingly incorporates molecular methods to understand microbial communities and their impacts on host biology. There's also a growing emphasis on climate change impacts on pollination systems and the development of resilient pollination strategies for future agricultural systems. Natural Environment Research Council (NERC, UK) College Member (2007-2010) Royal Entomological Society Symbiosis Special Interest Group Convenor (2005-2012) Editorial Board Member, Journal of Evolutionary Biology (2005-2008) NERC Advanced Research Fellow (1998-2003) SERC Research Fellow (1993-1995) Royal 1851 Commission Research Fellow (1991-1993) Australian Entomological Society Conservation Committee Member (2017-present) Invited collaboration with Professor Wan-Jin Liao's group at Beijing Normal University Professor Cook currently leads multiple significant research projects focused on pollination services for Australian horticulture. His grant portfolio includes projects on stingless bee husbandry , alternative pollinators including flies, and pollinator health . He collaborates extensively with researchers across Australia and internationally, with projects spanning from basic research on fig-wasp mutualisms to applied studies on crop pollination. Professor Cook has authored over 70 research articles and six book chapters, demonstrating sustained research productivity throughout his career. Professor Cook's research involves extensive field, laboratory, and glasshouse work, with a strong emphasis on molecular methods. His work connects with collaborators across Australia, India, China, France, the UK, and the USA, creating a robust international research network focused on pollination ecology and insect symbioses. His leadership in the Plants, Animals and Interactions research theme at HIE provides a framework for integrating fundamental ecological research with practical applications for sustainable agriculture and conservation.
Charles Bond is a Professor at the School of Molecular Sciences within the Faculty of Science at the University of Western Australia. With a PhD in Chemistry from the University of Manchester and additional training from the Australian Institute of Company Directors, he has established himself as a prominent researcher in structural biology and molecular interactions. Education: PhD in Chemistry, University of Manchester (1992-1996) Graduate, Australian Institute of Company Directors (2022) Bond's research focuses on understanding how the spatial arrangement of biological molecules in complexes dictates their function, with particular interest in protein:nucleic acid interactions and their roles in gene regulatory complexes in eukaryotes. His work combines expertise in crystallography, bioinformatics, biochemistry, and molecular biology, often through collaborations with experts in cell biology and other biophysical techniques. His research spans structural biology, molecular recognition, RNA-binding proteins, and the development of synthetic biology tools. Analysis of his recent publications reveals a strong emphasis on protein-nucleic acid interactions, structural dynamics of biomolecular complexes, and the application of structural biology to solve biological problems. His work increasingly incorporates computational approaches, including contributions to discussions about AlphaFold's impact on structural biology. He has made significant contributions to understanding pentatricopeptide repeat proteins, paraspeckle formation, and bacterial conjugation mechanisms. As an active member of the scientific community, Bond serves as a co-editor for Acta Crystallographica Section D and has reviewed for multiple high-impact journals including Nature Communications, Biochemistry, and The Plant Cell. His research has been supported by funding from the Marsden Fund for projects investigating molecular circuits and gene expression. Bond maintains an active laboratory focused on structural biology approaches to understand molecular interactions, with particular emphasis on protein-RNA complexes and their roles in cellular processes. His collaborative approach has led to productive partnerships across multiple disciplines, bridging structural biology with cell biology, biochemistry, and agricultural science.
Dr. Kai Chen is a Research Fellow and Head of the Molecular Biology and Imaging Laboratory (MBIL) at The University of Western Australia (UWA). He holds positions in the School of Biomedical Sciences and School of Molecular Sciences, with affiliations to the Centre for Human Lactation Research and Translation. Dr. Chen completed medical and orthopaedic surgery training in China, followed by a PhD in Bone Biology at UWA (2016–2019) and postdoctoral training in molecular imaging and nanobiotechnology (2020–2023). His research focuses on integrating light, electron, and ion microscopy to study skeletal biology, drug delivery, and disease mechanisms. Education: PhD in Bone Biology, UWA (2016–2019) Masters in Orthopaedic Surgery, Wenzhou Medical University (2012–2015) Bachelor of Medicine, Wenzhou Medical University (2007–2012) Research interests include skeletal disorders (osteoporosis, osteoarthritis), molecular imaging technologies, and nanobiotechnology. Current projects explore nanoscale metabolism in bone marrow, RNA drug trafficking, and spatial iron metabolism. Key awards include the European Calcified Tissue Society New Investigator Award (2024), Kaye Ibbertson Award (2023), and Raine Priming Grant (2023–2024). He leads multiple grants, including NHMRC Ideas Grant (2025–2028) and ARC Early Career Fellowship (2024–2027). Labs/Teams: MBIL focuses on correlative imaging workflows and drug delivery. Collaborations include projects on cancer metastasis, antisense technology, and multimodal microscopy platforms.
Associate Professor Jean (Jiayu) Wen holds positions at The Australian National University (ANU), including Group Leader of The Wen Group, ARC Future Fellow, and Deputy Director of The Shine-Dalgarno Centre for RNA Innovation. She specializes in computational and molecular biology, focusing on RNA regulation, gene expression, and cancer genomics. Her affiliations include ANU’s Division of Genome Sciences and Cancer, and the Centre for Computational Biomedical Sciences. Education: BEng in Electronic Engineering (Beijing), MSc in Computer Science (Lakehead University), PhD in Computational Biology (ANU). Postdoctoral training at Copenhagen University and Memorial Sloan-Kettering Cancer Center. Research interests span RNA structures, microRNA biogenesis, transcriptome dynamics, and epigenetic regulation. Her work addresses intragenomic conflicts, cancer mechanisms, and neural development. Notable projects include RNA-based machine learning models for RNA-RNA interactions and immune cell differentiation studies. Publications highlight contributions to RNA interference pathways, tumor development, and Drosophila genetics. Awards include the ARC Future Fellowship. She leads interdisciplinary teams advancing computational and experimental approaches in genomics and systems biology.
